Here, we describe a method to target a TAP specific siRNA to resident Clec9a expressing cross-presenting cDC1 cells in mice which led to inhibition of tumor growth, dispensing with the need to isolate and expand cDC1 in vitro. The gene discussed is CLEC9A; the disease is neoplasm.